Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Unintended Pregnancy May Modify Addiction Treatment

Am J Addictions; ePub 2018 Jul 11; Martin, et al

Publish date:: July 23, 2018

Unintended pregnancies intersect with opioid use disorder (OUD) and may modify one's treatment outcome, according to a recent study that examined how pregnancy intention affects OUD treatment. The primary exposure and outcome were pregnancy intention and treatment duration among MOTHER (Maternal Opioid Treatment: Human Experimental Research) participants (n=175). Researchers found:

Treatment durations were longer (21.3 vs 16.3 weeks) among intended (n=29) compared to unintended (n=146) pregnancy participants, but this was not significant in adjusted analyses.
OUD treatment may be a setting to help women implement informed family planning choices.

Citation:

Martin CE, Terplan M, O’Grady KE, Jones HE. Pregnancy intention and opioid use disorder treatment retention in the MOTHER study. [Published online ahead of print July 11, 2018]. Am J Addictions. doi:10.1111/ajad.12735.

This Week's Must Reads

MDD: Modest improvements in female sexual functioning with adjunctive brexpiprazole,

Transcranial direct current stimulation not clinically relevant in MDD,

Interleukin-1 β and TNF-α hamper antidepressant response in MDD,

Impact of pimavanserin on anxious depression in patients with MDD,

Prior MDD moderates the association between endothelin-1 and post-ACS depressive symptoms,

Must Reads in Addiction Medicine

E-cigarette use tied to increased COPD, asthma risk,

National lung cancer screening guidelines may miss younger African American individuals at high risk,

Alcohol problems linked to legal performance-enhancement products,

Report describes intoxication with new psychoactive substance,

Adolescent alcohol, opioid misuse linked to risky behaviors,